{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:34:17Z","timestamp":1793644457905,"version":"4.5.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0709"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0709"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.clineuro.2024.108229","type":"journal-article","created":{"date-parts":[[2024,3,3]],"date-time":"2024-03-03T06:11:52Z","timestamp":1709446312000},"page":"108229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting"],"prefix":"10.1016","volume":"239","author":[{"given":"Chenxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingsu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2024.108229_bib1","doi-asserted-by":"crossref","unstructured":"Correction to: 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2021;52(7):e483-e484. doi:10.1161\/STR.0000000000000383.","DOI":"10.1161\/STR.0000000000000383"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108229_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ejvs.2022.04.011","article-title":"Editor\u2019s Choice - European Society for Vascular Surgery (ESVS) 2023 clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease","volume":"65","author":"Naylor","year":"2023","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108229_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1124\/dmd.109.029132","article-title":"Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite","volume":"38","author":"Kazui","year":"2010","journal-title":"Drug Metab. Dispos."},{"issue":"20","key":"10.1016\/j.clineuro.2024.108229_bib4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1001\/jama.2011.1703","article-title":"Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease","volume":"306","author":"Mega","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clineuro.2024.108229_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1253\/circj.CJ-18-1386","article-title":"Association of CYP2C19 polymorphisms with clopidogrel reactivity and clinical outcomes in chronic ischemic stroke","volume":"83","author":"Tanaka","year":"2019","journal-title":"Circ. J."},{"issue":"23","key":"10.1016\/j.clineuro.2024.108229_bib6","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000072771.11429.83","article-title":"Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity","volume":"107","author":"Gurbel","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108229_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1001\/jama.2016.8662","article-title":"Association between CYP2C19 loss-of-function allele status and efficacy of clopidogrel for risk reduction among patients with minor stroke or transient ischemic attack","volume":"316","author":"Wang","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108229_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.116.024913","article-title":"Genetic polymorphisms and clopidogrel efficacy for acute ischemic stroke or transient ischemic attack: a systematic review and meta-analysis","volume":"135","author":"Pan","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108229_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cns.12173","article-title":"The association between CYP2C19 genotype and of in-stent restenosis among patients with vertebral artery stent treatment","volume":"20","author":"Lin","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"27","key":"10.1016\/j.clineuro.2024.108229_bib10","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","article-title":"Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA","volume":"385","author":"Wang","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108229_bib11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jvs.2020.04.518","article-title":"Outcomes and strategy of tailored antiplatelet therapy with ticagrelor in patients undergoing transcarotid artery revascularization","volume":"73","author":"Ghamraoui","year":"2021","journal-title":"J. Vasc. Surg."},{"issue":"4","key":"10.1016\/j.clineuro.2024.108229_bib12","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jvs.2021.09.045","article-title":"Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting","volume":"75","author":"Marcaccio","year":"2022","journal-title":"J. Vasc. Surg."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108229_bib13","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1182\/blood-2006-04-013052","article-title":"Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects","volume":"108","author":"Hulot","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clineuro.2024.108229_bib14","article-title":"Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting","volume":"75","author":"Cl","year":"2022","journal-title":"J. Vasc. Surg."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108229_bib15","article-title":"CYP2C19 Loss-of-function is associated with increased risk of ischemic stroke after transient ischemic attack in intracranial atherosclerotic disease","volume":"30","author":"Patel","year":"2021","journal-title":"J. Stroke Cereb. Dis."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108229_bib16","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.3171\/2015.6.JNS15795","article-title":"CYP2C19 and CES1 polymorphisms and efficacy of clopidogrel and aspirin dual antiplatelet therapy in patients with symptomatic intracranial atherosclerotic disease","volume":"124","author":"Hoh","year":"2016","journal-title":"J. Neurosurg."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108229_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/STR.0000000000000375","article-title":"Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke association","volume":"52","author":"Kleindorfer","year":"2021","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.clineuro.2024.108229_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1212\/WNL.0000000000200030","article-title":"Stroke prevention in symptomatic large artery intracranial atherosclerosis practice advisory: Report of the AAN guideline subcommittee","volume":"98","author":"Turan","year":"2022","journal-title":"Neurology"},{"key":"10.1016\/j.clineuro.2024.108229_bib19","article-title":"Association of CYP2C19 polymorphisms with the clinical efficacy of clopidogrel therapy in patients undergoing carotid artery stenting in Asia","volume":"6","author":"Zhu","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108229_bib20","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1038\/s41598-021-85580-0","article-title":"Association between CYP2C19 polymorphisms and clinical outcomes in patients undergoing stent procedure for cerebral artery stenosis","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.clineuro.2024.108229_bib21","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2015.1693","article-title":"Effect of a balloon-expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial","volume":"313","author":"Zaidat","year":"2015","journal-title":"JAMA"},{"issue":"9914","key":"10.1016\/j.clineuro.2024.108229_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(13)62038-3","article-title":"Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial","volume":"383","author":"Derdeyn","year":"2014","journal-title":"Lancet"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T19:29:05Z","timestamp":1736278145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724001161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":22,"alternative-id":["S0303846724001161"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108229","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108229","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108229"}}